CIB vs. NVS
CIB (Bancolombia S.A.) and NVS (Novartis AG) are both stocks. CIB operates in Banks - Regional (Financial Services), while NVS operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, CIB returned 14.75%/yr vs 10.33%/yr for NVS. At a 0.20 correlation, their price movements are largely independent.
Performance
CIB vs. NVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CIB achieves a 14.89% return, which is significantly higher than NVS's 9.43% return. Over the past 10 years, CIB has outperformed NVS with an annualized return of 14.75%, while NVS has yielded a comparatively lower 10.33% annualized return.
CIB
- 1D
- 1.30%
- 1M
- 10.00%
- YTD
- 14.89%
- 6M
- 17.10%
- 1Y
- 69.72%
- 3Y*
- 51.05%
- 5Y*
- 29.38%
- 10Y*
- 14.75%
NVS
- 1D
- -1.84%
- 1M
- 0.27%
- YTD
- 9.43%
- 6M
- 15.91%
- 1Y
- 27.84%
- 3Y*
- 17.18%
- 5Y*
- 13.87%
- 10Y*
- 10.33%
CIB vs. NVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CIB Bancolombia S.A. | 14.89% | 124.16% | 13.78% | 22.08% | -0.31% | -20.69% | -22.31% | 47.45% | -0.72% | 11.41% |
NVS Novartis AG | 9.43% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 5.95% | 19.42% |
Correlation
The correlation between CIB and NVS is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 1996 | 0.20 |
Fundamentals
CIB:
$17.04B
NVS:
$280.54B
CIB:
$29.17K
NVS:
$6.99
CIB:
0.00
NVS:
20.95
CIB:
0.00
NVS:
1.42
CIB:
0.00
NVS:
5.06
CIB:
0.00
NVS:
7.28
CIB:
$43.34T
NVS:
$56.05B
CIB:
$25.71T
NVS:
$42.19B
CIB:
$10.37T
NVS:
$22.40B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CIB vs. NVS — Risk / Return Rank
CIB
NVS
CIB vs. NVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bancolombia S.A. (CIB) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CIB | NVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.85 | ||
| Sortino ratioReturn per unit of downside risk | +1.01 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.24 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 2.93 | 2.21 | +0.72 |
| Martin ratioReturn relative to average drawdown | 7.27 | 5.43 | +1.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CIB | NVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.20 | 1.36 | +0.85 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.90 | 0.74 | +0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.41 | 0.53 | -0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.25 | 0.42 | -0.17 |
Drawdowns
CIB vs. NVS - Drawdown Comparison
The maximum CIB drawdown since its inception was -93.77%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for CIB and NVS.
Loading charts...
Drawdown Indicators
| CIB | NVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.77% | -42.10% | -51.67% |
Max Drawdown (1Y)Largest decline over 1 year | -23.95% | -12.65% | -11.30% |
Max Drawdown (3Y)Largest decline over 3 years | -23.95% | -19.95% | -4.00% |
Max Drawdown (5Y)Largest decline over 5 years | -46.85% | -20.42% | -26.43% |
Max Drawdown (10Y)Largest decline over 10 years | -70.38% | -26.03% | -44.35% |
Current DrawdownCurrent decline from peak | -13.55% | -10.52% | -3.03% |
Average DrawdownAverage peak-to-trough decline | -32.62% | -10.93% | -21.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.63% | 5.14% | +4.49% |
Volatility
CIB vs. NVS - Volatility Comparison
Bancolombia S.A. (CIB) has a higher volatility of 12.58% compared to Novartis AG (NVS) at 6.16%. This indicates that CIB's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CIB | NVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.58% | 6.16% | +6.42% |
Volatility (6M)Calculated over the trailing 6-month period | 26.42% | 14.45% | +11.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.85% | 20.63% | +11.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.68% | 18.85% | +13.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.74% | 19.62% | +16.12% |
Dividends
CIB vs. NVS - Dividend Comparison
CIB's dividend yield for the trailing twelve months is around 1.70%, less than NVS's 3.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CIB Bancolombia S.A. | 1.70% | 6.90% | 10.96% | 10.92% | 10.68% | 0.87% | 4.01% | 2.41% | 3.62% | 3.21% | 3.21% | 4.49% |
NVS Novartis AG | 3.26% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
Financials
CIB vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Bancolombia S.A. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CIB vs. NVS - Profitability Comparison
CIB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bancolombia S.A. reported a gross profit of 6.19T and revenue of 10.46T. Therefore, the gross margin over that period was 59.2%.
NVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.
CIB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bancolombia S.A. reported an operating income of 2.15T and revenue of 10.46T, resulting in an operating margin of 20.5%.
NVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.
CIB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bancolombia S.A. reported a net income of 1.46T and revenue of 10.46T, resulting in a net margin of 13.9%.
NVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.
Frequently Asked Questions
CIB and NVS have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CIB has higher volatility (12.58%) compared to NVS (6.16%). In terms of maximum drawdown, CIB dropped -93.77% vs NVS's -42.10%.
CIB currently has the higher Sharpe Ratio (2.20 vs 1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CIB and NVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer